Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation by Arianna Lorusso et al.
ORIGINAL ARTICLE
Activity-based cost analysis of contrast-enhanced
ultrasonography (CEUS) related to the diagnostic impact in focal
liver lesion characterisation
Arianna Lorusso & Emilio Quaia & Gabriele Poillucci &
Fulvio Stacul & Guido Grisi & Maria Assunta Cova
Received: 17 September 2014 /Revised: 18 February 2015 /Accepted: 19 February 2015 /Published online: 9 May 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Purpose This study was done to assess the clinical-
diagnostic impact and cost of contrast-enhanced ultra-
sound (CEUS) versus computed tomography (CT) and
magnetic resonance (MR) imaging in the characterisation
of focal liver lesions.
Materials and methods CEUS with sulphur hexafluoride-
filled microbubbles (SonoVue bolus 2.4 ml) was performed
in 157 patients with 160 focal liver lesions identified by other
diagnostic techniques. CEUS images were obtained during
the arterial (15 to 35 s from contrast injection), portal venous
(40 to 70 s) and late phase (up to 300 s from microbubble
injection). Contrast-enhanced CT was performed with a 64-
row multidetector CT. MRI was performed before and after
administration of the liver-specific contrast agent gadobenate
dimeglumine (Gd-BOPTA). A patient-by-patient activity-
based cost analysis was performed.
Results CEUS led to a change in the diagnostic workup in
131/157 patients (83.4 %) and in the therapeutic workup in
93/157 patients (59.2 %). CEUS allowed for the final diagno-
sis to be established in 133/157 patients (84.7%). The full cost
of CEUS was lower than that of contrast-enhanced CT and
MR imaging.
Conclusions CEUS determined a change in the diagnostic
and therapeutic workup in the characterisation of focal liver
lesions and reduced the full costs of the diagnostic process.
Main messages:
• CEUS allows a correct diagnosis in more than 80% of focal
liver lesions.
•CEUS has a significant impact on the diagnosis of focal liver
lesions.
• CEUS examination of focal liver lesions reduces total costs.
• Dynamic MR with hepato-specific contrast medium remains
the reference standard for lesion characterisation.
• CEUS is low-cost, versatile and accurate in the characteri
sation of focal liver lesions.
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Greyscale ultrasound (US) in the study of the liver is a nonin-
vasive, inexpensive and readily accessible technique. In spite
of continuous technological advancements, ultrasound is
characterised by low specificity in the study of focal hepatic
lesions and has an overall accuracy of about 50 % [1]. Colour
Doppler and pulsed Doppler modules provide useful supple-
mentary information for characterising focal hepatic lesions,
with limitations related to breathing and cardiac pulsatility
artefacts, allowing only the study of the macrocirculation, as
smaller vessels cannot be visualised [2, 3].
Contrast-enhanced US (CEUS) is now recognised as a
highly accurate test in the detection and characterisation of
focal hepatic lesions [2, 4–6]. It is a minimally invasive
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(considering the required venous access), repeatable technique
that is readily available in the ultrasound suite, has high con-
trast and temporal resolution, and allows dynamic evaluation
of lesions in real time [2–7].
CEUS has comparable sensitivity and specificity to com-
puted tomography (CT) and magnetic resonance imaging
(MRI), albeit with limitations related to the lack of
panoramicity and the physical impediments to ultrasound pen-
etration in the presence of obesity and bowel gas [9–11].
Only a limited number of studies in the literature have
carried out a cost analysis of hepatic CEUS [12–15].
The aims of our study were to evaluate the clinical-
diagnostic impact of CEUS for the characterisation of focal
hepatic lesions in healthy, cirrhotic and oncologic patients and
to analyse the cost of CEUS in comparison to multiphase CT




A prospective study was conducted on a consecutive series of
157 patients (74 males and 83 females; age range, 30–92
years; mean age, 61.4 years) with 160 focal liver lesions ex-
amined between 30 March 2010 and 30 March 2011. All
subjects gave their informed consent to undergo the imaging
procedure.
There were 80 patients with a normal liver, 44 patients with
a known primary malignancy and 33 patients with liver cir-
rhosis. In our radiology department CEUS is used as a second-
level technique after detection of focal liver lesions in both the
normal and cirrhotic liver according to the 2004 and 2011
EFSUMB guidelines [16, 17]. In fact, the study included all
patients who underwent liver CEUS as a second-level inves-
tigation for the characterisation of focal lesions detected on
other imaging techniques and considered indeterminate by the
operator; in more detail, in 74 patients CEUS was carried out
after baseline ultrasound, in 77 after CT, in 5 after MR imag-
ing and in 1 after scintigraphy (Indio-111 octreotide).
As for the lesions detected on unenhanced US, these were
newly discovered focal lesions in patients with a known pri-
marymalignancy in 9 cases, suspicious findings for malignan-
cy in patients with cirrhosis in 22 cases, newly detected find-
ings that could not be characterised on unenhanced US in 11
cases, focal liver lesions discovered incidentally during
unenhanced US examinations performed in an emergency set-
ting in 12 cases and focal lesions identified but not
characterised at another institution in 20 cases.
As for the indeterminate focal liver lesions detected with
CT, 32 were identified during a staging or follow-up exami-
nation performed with a single-contrast phase in patients with
known malignancy, 10 were suspicious lesions in patients
with cirrhotic livers, 7 were incidental findings on CTangiog-
raphy (n=4) or CT urography (n=3), 17 were incidental find-
ings during single- or dual-phase emergency CT, 5 were le-
sions presenting an atypical dynamic contrast pattern on mul-
tiphase CT, and 6 were lesions detected with single- or dual-
phase CT at other institutions/hospitals and not characterised.
Of the five cases of CEUS performed after MR imaging, 2
had MR findings compatible with atypical haemangioma in
high-risk patients, two required differentiation between well-
differentiated hepatocellular carcinoma (HCC) nodules and
benign lesions, and one was a request for further contrast-
enhanced investigation to confirm a suspicion of single me-
tastasis in a cancer patient (known malignancy).
The single patient who underwent CEUS after positive
scintigraphic examination (patient with colon carcinoma and
focal uptake in the liver area) underwent CEUS to remove any
doubts relating to the finding.
Examination technique
Liver CEUS was conducted with Sequoia S2000 equipment
(Acuson-Siemens, Mountan View, CA) in 133 patients and
with an Aplio XG system (Toshiba Medical Systems,
Tokyo, Japan) in 24 patients. After performing an initial base-
line greyscale study and colour and/or power Doppler imaging
with multifrequency convex probes in order to identify the
lesion and select the best scanning plane, we proceeded to
cannulate a forearm vein and carry out the CEUS study. A
bolus of sulphur hexafluoride microbubbles (SonoVue ®
Bracco Imaging, Milan, Italy) was injected at an average dose
of 2.29 ml (mode and median, 2.4 ml) followed by a 10-ml
saline bolus chase. The arterial phase was set at 15–35 s from
contrast administration, the venous phase at 40–70 s and the
late phase up to 300 s. The contrast-specific techniques used
were cadence contrast pulse sequencing (CPS) (Acuson-
Siemens, Mountan View, CA) and a tissue contrast discrimi-
nator (Toshiba Medical Systems, Tokyo, Japan) with a me-
chanical index of 0.09–0.14, a dynamic range of 65 dB and a
temporal resolution between 75 and 100ms (10–13 frames per
second). Signal amplification was adjusted below visibility of
noise and the focus immediately below the lesion.
Four-phase CT was conducted using 64-slice equipment
(Aquilion, Toshiba Medical Systems, Tokyo) with the follow-
ing technical parameters: 400-ms rotation time, 64 × 0.5-mm
collimation, pitch normalised at 1, 32-mm Z-axis coverage,
0.3-mm reconstruction interval, 120 kV, 180–250-mAs tube
current intensity in relation to patient size and 40-cm field of
view. The images were reconstructed with a field of view of
25–35 cm in relation to the physical constitution of the patient.
We acquired unenhanced, arterial, portal and late phase scans
after the intravenous bolus administration of 120 ml of iodin-
ated contrast medium (iopromide) at a concentration of 370
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mg/ml at a flow rate of 5 ml/s, followed by a 50-ml saline
bolus. The arterial phase was acquired using the bolus track-
ing technique with a delay of 18 s after a threshold of 140 HU
had been reached in a region of interest (ROI) placed over the
abdominal aorta. The portal and late phases were acquired
with a delay of 70–80 s and 180–210 s, respectively, from
the beginning of contrast administration.
MR o f t h e l i v e r w a s p e r f o rm e d u s i n g a
superconducting magnet operating at 1.5 T (Achieva,
Philips Medical Systems, The Netherlands). Axial acqui-
sitions were obtained during an expiratory breath-hold
using a four-channel phased-array surface coil and
breathing synchronisation. The following sequences were
used: T2-weighted single-shot turbo spin-echo (SS TSE)
(TR/TE, 593/80), T2-weighted inversion recovery with
fat suppression (SPAIR) (TR/TE, 448/80), in-phase and
out-of-phase T1-weighted fast field echo (FFE) (TR/TE,
332/4.6-2.3) and T1-weighted high-resolution isotropic
volume examination (THRIVE) with fat suppression
(TR/TE, 3.2/1.62) performed before and after the admin-
istration of 0.2 mmol/kg gadobenate dimeglumine (Gd-
BOPTA) into a vein of the arm at a flow rate of 2 ml/s
and followed by 20 ml of saline bolus chase. The arterial
phase was acquired using the bolus chase technique with
a delay of 5–10 s after visualisation of the contrast me-
dium at the level of the abdominal aorta. The portal and
late phases were acquired with a delay of 70–80 and
180–210 s, respectively. Finally, a hepatobiliary phase
was acquired at 1.5–2 h after the administration of con-
trast medium.
Image evaluation
The images were evaluated on a PACS (picture archiving and
communications system)-integrated workstation (19-inch
TFT display, resolution 2,560 × 1,600 pixels, EBIT AET
Health, Genoa, Italy) by the radiologist who performed the
examination. In particular, three radiologists with 5, 14 and
15 years of experience in liver imaging reviewed the CEUS
images, another three radiologists with 9, 13 and 14 years of
experience reviewed the CT images, and two radiologists with
9 and 12 years of experience reviewed the MR images.
Evaluation of the CEUS images was performed in real
time, whereas the CT images were reviewed just after the
acquisition and reconstruction of the four phases
(unenhanced, arterial, portal and late phase); the characterisa-
tion of focal liver lesions on MR imaging required waiting
until after the acquisition of the hepato-specific phase
60 min after administration of the contrast medium.
We used the reference criteria reported in the literature for
CEUS [18] and MR imaging and CT [3] for lesion character-
isation or to propose a possible nature diagnosis, benign or
malignant, for each focal liver lesion.
Cost analysis
For the purposes of the economic assessment we used a meth-
od already applied in previous studies [19] and in industrial
settings [20] to compare the relative costs of the three imaging
techniques used for the characterisation of liver lesions:
CEUS, CT and MR imaging.
For CEUS, data were collected for 157 patients. Given that
only a small percentage of these patients required subsequent
assessment with multiphase CT (n=6 ) and/or dynamic MR
imaging with hepato-specific contrast material (n=13), the
variable costs and personnel costs for these two modalities
were calculated on a sample of 50 patients with focal liver
lesions.
For each technique, we calculated and compared the full
cost, defined as the sum of the variable costs and fixed costs of
capacity (technology and staff costs), which represents the
most relevant cost component as it differs among CEUS, CT
andMR imaging; the indirect costs of the department were not
taken into account as they do not depend on the application of
the three techniques.
For each method, the cost of the technology was calculated
based on the purchase cost of the equipment, obtained from
the official hospital documentation, and depreciation over
time considered at a constant annual rate except in cases in
which the degradation of the device was available. The useful
economic lifespan of the equipment was defined as 10 years,
i.e., the maximum time that includes both technological obso-
lescence and degradation of care efficacy.
For each investigation, we then assessed the variable costs
relating to the type and quantity of materials and services
related to its use.
Subsequently, we evaluated the personnel costs in terms of
physician time (person responsible for the activity, including
staff radiologists and trainee radiologists) and radiology tech-
nician and nursing staff time, considering the specific activi-
ties undertaken by the various professionals for each of the
three imaging techniques; this provided a calculation of both
fixed and variable costs closely reflecting the current situation
at our university hospital.
The costs of fixed asset utilisation (technology and staff
costs) were obtained from time measurements of the use of
capacity that these production factors offer.
The calculated costs of materials and equipment are inclu-
sive of value added tax at 20 %.
Then we calculated the common costs, which corre-
spond to the internal costs of the production factors of
the radiology division and are necessary for providing
services common to all diagnostic activities carried out
within the division. These include capacity costs related
to personnel and support materials, which remain con-
stant, regardless of the total number of examinations per-
formed in a year.
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Finally, we considered the external costs to the radiology
division for each of the imaging techniques being compared:
in particular, the costs arising from determination of serum
creatinine levels (performed in all patients undergoing CT or
contrast-enhanced MR imaging) and those arising from anti-
allergic preparations through the use of corticosteroids asso-
ciated with anti-H1 and anti-H2 (performed in all patients
undergoing CT with a history of moderate and severe reac-
tions to iodinated contrast media or a history of asthma or
allergy requiring medical treatment).
The total cost for each investigation, and hence the cost of
the diagnostic process, is given by the sum of the full costs,
common and external costs.
We computed the actual historical full cost for the three
different imaging techniques, CEUS, CT and MR imaging,
which corresponds to average costs. We followed an
activity-based method [36] consisting of two tasks: producing
the images and reporting. In our case the second task closely
follows the first one; it is performed in the same cost and
responsibility department, and its cost is computed separately
(as lead time times cost per hour); therefore, the two tasks are
additive.
The economic evaluation method is cost-effectiveness
[20], namely the diagnostic effectiveness, as an intermediate
time of the whole treatment process. We assumed the provider
point of view for the costs. We excluded the costs for the




Table 1 shows the overall diagnostic impact provided by
CEUS in our series. CEUS helped to propose a correct diag-
nosis in 133 out of 160 focal liver lesions investigated (see
Fig. 1 for further details), providing a diagnosis of benign
lesions in 94/133 cases (70.7 %) and malignant lesions in
26/133 cases (19.5 %) as well as a correct suggestion toward
a benign or malignant lesion nature in 10/133 (7.5 %) and
3/133 cases (2.3 %), respectively (Fig. 2). The 120 liver
lesions that were correctly characterised by CEUS were: 46
angiomatous lesions, 20 areas of macrovesicular steatosis, 16
cystic lesions, 7 regenerative nodules, 3 focal areas of altered
perfusion, 1 case of focal nodular hyperplasia (FNH), 1 case of
wound abscess following cholecystectomy, 14 HCCs and 12
metastases.
Economic evaluation
Table 2 shows the results of economic analysis of CEUS, CT
and MR imaging.
Contrast-enhanced ultrasound
(1) Equipment costs (depreciation and maintenance)
The analysis considered the Sequoia Acuson S2000
ultrasound system (Siemens Mountan View, CA), for
which the cost to be amortised (i.e., purchase cost minus
residual value, here set at 0) was €117,120.00. The an-
nual cost over 10 years’ amortisation was €11,712 cal-
culated according to the equipment life span.
Considering 300 days of practical annual capacity, a sin-
gle daily 6-h shift in the ultrasound section and an aver-
age CEUS examination time of 17.4 min (measured on
157 patients imaged with CEUS), the equipment costs
amounted to €1.88 per examination.
(2) Variable costs (materials and related services)
The performance of liver CEUS involves the use of
sonographic contrast material (SonoVue, Bracco) in 4.7-
ml bottles (€80.99). The average dose administered per
patient was equal to 2.3 ml, for a cost of €39.63.
Additional materials were a 10-ml vial of saline solution
(€0.065), 20-G Abbocath needle cannula (€0.32 ), 10-ml
sterile disposable syringe (€0.066 ), injection stopper
(€0.041), ultrasound gel (cost per jar €0.51, at an average
of 15 examinations per jar, €0.034 per examination) and
disposable gloves (one pair for the radiologist
performing the survey and another for the trainee radiol-
ogist, for a total cost of €0.067). In addition, outpatients,
who account for 6–7 % of the liver CEUS examinations
performed at our institution, receive a CD-ROMwith the
images (€0.32).
The sum of the costs resulted in a variable cost of
€40.18 per examination.
(3) Staff costs
The actual time of activity for a radiologist is equal to
175.95 days/year with an effective daily shift of 7.6 h.
This results in an hourly cost of €75.80 and a cost per
minute of €1.26.
On the basis of 157 examinations performed, we mea-
sured the average procedure time to be 17.3 min and the
average reporting time to be 7.4 min, for a total average
radiologist time of 24.7 min per patient. Multiplying the
Table 1 The overall clinical impact provided by contrast-enhanced US













157 157/157 131/157 93/157
100 % 83.4 % 59.2 %
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cost/minute of the radiologist (€1.26) by the average time
per patient (24.7 min) gives a “radiologist cost” of €31.20
per examination.
As for the cost of trainee radiologists (residents), who
are required to participate actively in CEUS investigations
at our hospital, we considered an average of 210 working
days per year, estimated based on specific provisions of
national, European and international research programmes,
and calculated subtracting ordinary leave, extraordinary
leave and sick leave (5 %). We therefore considered an
average of 7.2 h per day for 210 working days per year
at an hourly cost of €16.70 and €0.28 per minute. The
resident physician has a role in patient preparation,
illustration of informed consent, vein cannulation and ad-
ministration of the contrast medium. The average trainee
radiologist time is equal to the average procedure time
(17.3 min), plus the time required to explain the examina-
tion and take the vein (7 min), for a total of 24.3 min. The
result is a “trainee radiologist” cost of €6.80 per examina-
tion. Thus, the full cost of a CEUS examination is €80.14.
Multiphase CT
(1) Equipment costs (depreciation and maintenance)
























Fig. 2 Total number and
percentage of lesions suspected or
characterised as benign or
malignant though CEUS
Fig. 1 Percentage of lesions
suspicious or characterised as
benign or malignant after CEUS
examination
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scanner (Toshiba Medical Systems, Tokyo). The cost to
be amortised is equal to the purchase cost (without
subtracting a residual value) and is €1,242,000. This re-
sults in an annual cost of €124,200 for a 10-year
amortisation. To this we must add the cost of the main-
tenance contract, amounting to €99,360 per year, and the
cost of the injection pump (including routine annual
maintenance) of €4,056 (equal to €405.6 per year). The
sum of the annual depreciation over 10 years and the
annual cost of the maintenance contracts results in an
annual equipment cost of €223,966.
Assuming 300 days of practical capacity, the daily
cost is €746.6. Assuming an hourly cost of €62.21 with
a single daily 12-h shift in the CT section and an average
CT investigation time of 20 min, the equipment costs
amount to €20.74 per examination.
(2) Variable costs (materials and related services)
Performance of a hepatic multiphase CT involves the
use of 120 ml of iodinated contrast medium at a concen-
tration of 370 mgI/ml (iopromide) in 500-ml bottles
(€159.76), for a cost of €38.34.
Additional materials include 30-ml bottles of saline
solution (negligible cost of €0.31 per 250 ml), a set of
disposable syringes for the injection pump with a unit
cost of €24, 20-G Abbocath (€0.32), spiral connector
(€2.95) and pair of disposable gloves (€0.037). Costs
for the disinfectant, cotton ball and plaster are negligible.
Outpatients (about 28 %) are also given a CD-ROM of
the images (€0.32). The result is a cost per examination
of €0.084.
Also included in the analysis was the wear of the X-
ray tube (this is a depreciation calculated according to
use and thus a variable cost): we calculated that the av-
erage number of shots per scan is 45. The purchase cost
of the X-ray tube is €91,800 and its expected life is equal
to 300,000 shots, with a cost of €0.30 per shot, for a cost
of €13.77 per examination.
The sum of the values results in a variable cost of
€79.82 per examination.
(3) Staff costs
Radiologist time is related to the various activities to
be carried out: evaluation and planning of the investiga-
tion in relation to the clinical question (principle of jus-
tification), monitoring and evaluation of images in the
different contrast-enhanced scans, comparison with pre-
vious examinations and reporting.
On this basis, the analysis carried out on a sample of
50 patients showed that multiphase CT of the liver in-
volves a mean radiologist time of a total of 19.7 min,
equal to a “radiologist cost” of €23.52 per examination.
At our hospital, trainee radiologists are also required
to attend CTexaminations, where their role is to correctly
explain the procedure, collect the patients’ history of
allergy to iodine-based compounds, verify laboratory
tests (creatinine) and provide the patient with all the in-
formation needed for informed consent to the procedure.
The average trainee radiologist time is 7 min, with a
resulting “trainee radiologist cost” amounting to €1.96.
Every multiphase CT study involves the use of 20-
min technician time.
The annual cost of the radiology technician amounts
to €40,078.52. Subtracting from the annual working
hours absences due to ordinary leave (44 days), extraor-
dinary leave and sick leave (average 30 %), a techni-
cian’s actual working time is 178.5 days of 7.2 produc-
tive hours. The cost per hour being €31.18 and the cost
per minute €0.52, we have a “radiology technician cost”
equal to €10.39 per examination.
The CTexamination must also be attended by a nurse
who has a role in patient preparation and contrast mate-
rial administration. In our sample, the average time need-
ed for nurses to perform these activities (i.e., patient re-
ception and preparation, vein cannulation) was equal to
20 min.
We considered an annual cost of €39,256 per nurse.
Annual ordinary leave for nurses is 32 days a year.
Nurses work 35 weeks per year and 36 h per week.
Subtracting the annual ordinary and extraordinary leave,
we have a total of 188.7 working days of 7.2 productive
hours. This yields a cost per hour equal to €28.89 and a
cost per minute of €0.482. The “nursing staff cost” is
therefore €9.63 per examination.
The full cost of a multiphase CT examination of the
liver at our institution is therefore €149.73.
CE dynamic MR imaging
(1) Equipment costs (depreciation and maintenance)
We considered the current cost of an Achieva 1.5-T
Table 2 Cost analysis of the three imaging techniques: CEUS,
multiphasic CT and dynamic MRI
CEUS CT MR imaging
Full costs (€)
Equipment 1.88 20.74 36.40
Variable costs 40.26 79.82 67.77
Medical doctors 31.20 24.89 37.86
Residents 6.80 1.96 4.56
Radiographers 0 10.39 20.79
Nurses 0 9.63 0
Common costs (€) 5.3 5.3 5.3
External costs (€) 0 2.3 1.9
Total costs (€) €85.44 € 155.03 € 174.58
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MR device (Philips Medical System, The Netherlands).
The cost to be amortised (equal to the purchase cost) is
€1,000,000. This results in an annual cost of €100,000
for a 10-year amortisation. To this we added the costs of
maintenance, amounting to €94,758 per annum. The pur-
chase cost of the injection pump is €18,000 with an an-
nual cost of €1,800. The routine maintenance of the
pump at our institution is the responsibility of Clinical
Engineering, so the cost is not incurred by the Division
of Radiology.
The sum of the annual depreciation for 10 years and
annual costs for maintenance contracts results in an an-
nual equipment cost of €196,558. Assuming 300 days of
practical capacity, the daily cost is €655.19. Considering
an hourly cost of €54.6 with a single 12-h daily shift, and
an equipment time of 40 min for this investigation
(30 min for the first part of the acquisition and another
10 min for the late acquisition starting 1 h after contrast
administration), the result is a “total equipment cost” of
€36.4.
(2) Variable costs (materials and services)
At our institute, dynamic MR imaging of the liver
involves the use of the hepato-specific contrast medium
Gd-BOPTA (gadobenate dimeglumine) in 20-ml bottles
(€57.07). In our sample, an average of 14 ml was used,
for a cost of €39.95. Further materials include: approxi-
mately 20 ml of saline solution whose cost is negligible;
a set of disposable syringes for the injection pump with a
unit cost of €24; a spiral connector with a cost of €2.95; a
20-G Abbocath (€0.32); two pairs of disposable gloves
(€0.074); a small amount of disinfectant; a cotton wool
ball and a bandage. Outpatient referrals, which account
for approximately 33.3 % of requests for liver MRI stud-
ies performed at out institution, are provided with a CD-
ROM of the images.
The variable cost is therefore €67.77 per examination.
(3) Staff costs
Radiologist working time is related to the various ac-
tivities performed in the MR section: investigation ap-
proval and settings, evaluation of any previous imaging
investigations and evaluation of scans acquired during
the different post-contrast phases, and reporting. In addi-
tion, in dynamic liver MR imaging, also the hepato-
specific phase (the late acquisition at 1 h after adminis-
tration of contrast material) is assessed.
In the sample of 50 patients who underwent the sur-
vey, we estimated an average radiologist time of
29.97 min, for a cost of €37.86.
At our hospital, the MR unit is always attended by a
trainee radiologist who has a role in explaining the mo-
dality, assessing patient compatibility by administering a
questionnaire and obtaining informed consent. Trainee
radiologists are also involved in vein cannulation.
Based on an average trainee radiologist time of
16.3 min, the “trainee radiologist cost” is €4.56.
Each liver MR imaging investigation involves about
30 min technician time for the first stage and an addition-
al 10 min for the hepato-specific phase 1 h after admin-
istration of the contrast agent. This results in a total tech-
nician time of 40 min, which, multiplied by the
cost/minute, provides a “radiology technician cost” of
€20.79.
The full cost of a dynamic liver MR imaging investi-
gation at our institution is therefore €169.34.
Common costs
“Common costs” are taken to refer to the cost of production
factors internal to the radiology division and involved in gen-
erating a wide range of services common to all diagnostic
activity performed within the division. These are capacity
costs that do not vary despite even major changes in the total
number of examinations carried out over the year. Common
costs are costs pertaining to the support staff, i.e., all those
professionals not mentioned above who work to help run the
institute regardless of the type of examination (head of divi-
sion, chief radiology technician, auxiliary staff, archive tech-
nicians, administrative clerks and assistants) and support ma-
terials (computers, printers, recorders, electrical and network
equipment, stationery, cleaning supplies). Over the year, the
total cost for these workers was €601,735 and the total number
of examinations was 126,592, resulting in an additional com-
mon cost of €4.8 per examination. The cost of the support
material was estimated to be €0.50 per procedure. Therefore
the total cost of personnel and support material amounted to
€5.30.
External costs
All patients undergoing a CT investigation involving the use
of iodine-based contrast material routinely undergo blood test-
ing to assess serum creatinine levels. This also applies to those
undergoing MR imaging with the administration of the para-
magnetic contrast agent. This implies an external cost of €1.90
per examination for both multiphase CT and contrast-
enhanced dynamic MR imaging.
In addition, 1.1 % of patients undergoing CT have a history
of allergy that requires pharmacological prophylaxis (based
on corticosteroids associated with anti-H1 and anti-H2) at a
cost of €4, leading to an additional €0.40 on average for each
examination.
Overall, these external costs amount to €0 for CEUS, €2.3
for multiphase CT and €1.9 for dynamic MR imaging.
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Cost of the diagnostic process
The sum of the full costs, common costs and external costs
provides the cost of the diagnostic process for each imaging
modality taken into consideration (Table 2).
Considering that in our current economic context the item
that most affects the full cost of a modality is the cost of
technology, we compared the full cost of the three imaging
techniques, assuming the most unfavourable condition for
CEUS, that is, an up to 40 % decrease in the cost of technol-
ogy (equipment cost) of CTand MR imaging with unchanged
cost of US equipment.
Discussion
As is well established in the literature [3–9], CEUS is an easy-
to-perform investigation that has high diagnostic accuracy in
the characterisation of focal liver lesions. According to the
EFSUMB guidelines [16, 17] CEUS should be used in each
incidental focal liver lesion detected at unenhanced US, in
lesions or suspected lesions detected with unenhanced US in
patients with a known history of malignancy, when CTor MR
imaging is inconclusive, and to characterise all nodules found
on surveillance with US.
This is also evident from our results, as CEUS liver imag-
ing, performed as a second-level examination, thanks to the
reference diagnostic patterns reported in the literature [16, 1,
2, 4, 21, 22], proved to be diagnostic in 83.1 % of the lesions
investigated and allowed for lesion characterisation (without
the need for further imaging confirmation or follow-up) in
almost 90 % of these cases.
The CEUS survey is also much more objective than base-
line US: the operator must in fact observe the enhancement
behaviour of the lesions during the different post-contrast
phases to achieve correct characterisation without having to
take into account the complex semeiotics of conventional US
[1, 2, 4–7]. In addition, the correct performance and interpre-
tation of a CEUS examination requires experience as well as
adequate theoretical and practical training. CEUS is consid-
ered a completion of unenhanced US, the semiotics of which
the operator should know equally well. CEUS is an investiga-
tion that requires appropriate equipment and the use of
contrast-specific techniques [2, 23].
The data from our series, collected at a specific moment in
time in the setting of our department of radiology, reveal two
important aspects: in more than 80 % of the 157 patients
investigated, CEUS led to a real change in the diagnostic
workup that the clinician, after discussion with the radiologist,
would have followed if CEUS had not been available; in al-
most 60 % of cases, CEUS was able to determine a real
change in the clinical and therapeutic management of the
patient.
These data suggest that the technique has a major impact on
the clinical management of patients. It must be emphasised
that this conclusion is based on the clinician’s evaluation,
taking into account the impact of CEUS on daily activity,
but in the absence of a “gold standard”.
CEUS therefore appears to be a “problem-solving” tech-
nique able to orientate the diagnosis towards the benignity or
malignancy of a lesion that could not be characterised on other
imaging techniques with a high level of diagnostic accuracy
[4, 24–27].
In our series, only a limited number of patients could be
imaged with CEUS immediately after detection of the equiv-
ocal finding, as this depended on the availability of an ade-
quately experienced operator; in the majority of patients
CEUS was scheduled for a later date.
CEUS has the potential immediate effect of shortening the
diagnostic workup of patients with a newly detected focal
liver lesion by avoiding the need for more expensive addition-
al investigations, which are usually associated with longer
waiting times.
These aspects have been considered by several studies in the
literature: Faccioli et al. [12] conducted a study on 398 patients
showing that CEUS is the most economical second-level tech-
nique for the diagnosis of benign focal liver lesions, allowing
cost savings in the management of internal resources;
Romanini et al. [13] evaluated a series of 485 patients with 575
focal liver lesions and showed that the routine use of CEUS for
focal liver lesion characterisation leads to significant cost savings
while providing a diagnostic accuracy comparable toCTandMR
imaging, and allows the diagnostic process to be concluded in
87.6 % of cases without the need for additional imaging.
More recent studies have reported similar findings. In par-
ticular, Tranquart et al. [14] reported a clear economic advan-
tage for CEUS compared to CT and MR imaging, confirming
the high diagnostic value of CEUS in the characterisation of
focal liver lesions. A similar conclusion was reached by Sirli
et al. [15].
In settings in which the technique and expertise are avail-
able, CEUS can be performed in real time immediately after
detection of the finding. Given that the majority of incidental
focal liver lesions are benign, this could avoid unnecessary
extensions of the diagnostic workup, further reducing waiting
times or length of hospital stay and, consequently, costs.
Our study also found that CEUS often provides an addi-
tional diagnostic value for those focal liver lesions that cannot
be characterised on CT. This may happen in incidental focal
liver lesions presenting atypical enhancement or identified on
single-phase CT (usually portal phase), or when the amount of
iodinated contrast medium injected per minute is not appro-
priate to the patient’s body weight resulting in low contrast in
the liver, in small lesions in which evaluation of enhancement
proves difficult and in patients with inhomogeneous liver
echogenicity or also after chemo- or radiotherapy.
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In these cases, there is agreement in the literature [2, 8, 10,
18–22, 26–29] that CEUS represents an additional diagnostic
value thanks to its greater temporal resolution and its limited
field of view concentrated in the evaluation of a particular
sector of the liver with an resolution comparable to CT and
MR imaging.
The cost analysis performed in our study aimed to compare
the three imaging methods used for the characterisation of focal
liver lesions. Economic analysis is used to identify and make
explicit a set of criteria that can help in the process of choosing
between different resources. The main task of any economic
evaluation is to identify, measure, estimate and compare the costs
and consequences of the various alternatives considered [20].
New technologies, in particular at the time of their introduction
into clinical practice, may have high costs that can be justified by
demonstrating a real diagnostic and therapeutic impact. The ef-
fects of technological innovation on health spending depend
solely on its appropriate use, considering the diagnostic and/or
therapeutic strategies already available. These considerations are
even more valid in radiology as the costs of the devices and their
use have a significant impact on the total costs. In addition, as
also noted in our series, the radiological diagnosis significantly
affects the patient’s clinical management, treatment choices and
consequently the overall cost of the disease [30–33].
Our cost analysis of the three techniques used for liver
imaging—namely, CEUS, multiphase CT and contrast-
enhanced dynamic MRI—clearly shows that liver CEUS is
the most advantageous in economic terms. This finding is no
doubt related to the lower cost of the equipment, but also to the
smaller number of professionals involved and the lower im-
pact of variable costs (Table 2).
In addition, as shown in the sensitivity graph, even assuming
the worst case scenario, that is, that the cost of the ultrasound
scanner remains constant with maximum conceivable deprecia-
tion of the costs of CTandMR imaging technology, there is still
a clear economic advantage for CEUS examination of the liver.
Our cost analysis was carried out using a method common-
ly applied in industrial settings, which guarantees a rigour that
reduces approximations of conventional cost calculation
methods [30]. This analysis provides, however, a snapshot
of the situation of the Radiology Division at a particular mo-
ment in time, so the data cannot be extrapolated uncritically, as
in different settings the costs may differ greatly as a result of
both the equipment and materials available and organisational
decisions affecting the cost of personnel.
It should, however, be remembered that CEUS does not have
absolute diagnostic accuracy in the characterisation of focal liver
lesions and that dynamic MR imaging with hepato-specific con-
trast medium remains the reference standard for lesion character-
isation [3, 10, 22, 27, 29]. However, considering its high cost, the
use of MR imaging must necessarily be restricted to a limited
number of patients, i.e., those with focal liver lesions showing
equivocal enhancement at CEUS, those with lesions in locations
that cannot be explored with ultrasound or patients who are dif-
ficult to assess with ultrasound. However, microbubble contrast
agent with an additional postvascular (or Kupffer) phase, such as
Sonazoid, which is approved for liver imaging in Japan, could
further increase the overall diagnostic accuracy for CEUS [34],
especially in the cirrhotic liver [35].
Our study has some limitations. First, in our study we per-
formed a detailed comparative assessment of the full (technol-
ogy, variable and staff costs), common and external costs of
the three modalities and evaluated the diagnostic and thera-
peutic impact of CEUS. However, our evaluation of cost-
effectiveness cannot be considered complete in that we failed
to assess the impact of the different diagnostic strategies on the
patients’ survival and quality of life [28–31]. Second, the re-
sults of our cost analysis apply to our specific health care
setting since there is a signicant variation across European
countries in terms of salaries of medical doctors, nurses and
radiographers, and also in costs of imaging equipment, con-
trast agents and SonoVue. Moreover, the low cost of CEUS,
related to the examination time, applies to a health care setting
where CEUS is well established since CEUS is not part of
radiology training in many European countries.
In conclusion, liver CEUS represents a low-cost, versatile
and accurate technique in the characterisation of focal liver
lesions [5, 10, 13]. CT and MR imaging, while remaining
reference techniques for the characterisation of focal lesions,
are associated with longer waiting times and hospitalisation
before providing a definitive diagnosis, with resulting addi-
tional costs. Our study confirms that CEUS provides a viable
alternative to CT and MR imaging in the study of focal liver
lesions and that it can reduce the costs associated with the use
of more sophisticated diagnostic techniques by shortening the
diagnostic process and patient hospitalisation.
Conclusions
CEUS is an accurate diagnostic investigation in the character-
isation of focal liver lesions and it reduces the costs associated
with the use of more sophisticated diagnostic techniques.
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